A coronary stent is a tubular structured device made of a thin mesh of wire, which may also be coated with a polymer containing a drug, or made of biodegradable materials. Coronary stents are utilized during percutaneous coronary interventions (PCIs) for the treatment of patients suffering from various coronary artery diseases (CADs) such as acute myocardial infarction, angina pectoris and others. At present, several researches are being conducted in the field of coronary stenting, in order to minimize side effects such as restenosis and thrombosis. Certain new and advanced coronary stents such as bio-absorbable stents have been commercialized in the global market, which demonstrate very less or no common side effects of coronary stenting.
The market for coronary stents can be broadly classified into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. In 2011, the drug eluting stents segment held the largest share of the global coronary stents market, followed by the bare metal stents market. During the forecast period 2013 to 2019, the demand for bare metal stents is expected to be low and its overall growth will be offset by the increasing demand for other stent variants, mainly bio-absorbable stents. The bio-absorbable stents market has been predicted to be the fastest growing segment during the forecast period.
Some of the major factors that will be responsible for the growth of global coronary stents market during the forecast period include increasing prevalence of various coronary artery diseases, rising demand for new and advanced coronary stents, aging population and increasing obesity rates. According to World Health Organization (WHO) estimates, around 17.3 million people died from cardiovascular diseases in 2008 and it is expected that each year more than 23.3 million people will die due to cardiovascular diseases; this trend is predicted to continue till 2030. Among cardiovascular diseases, CADs are responsible for the highest number of deaths worldwide. However, according to the CDC, U.S., the number of deaths due to CADs has started decreasing due to increase in the number of PCIs being performed by using a range of coronary stents available in the global market.
North America holds the largest share in the global coronary stents market in terms of revenue. The key factor responsible for the dominance of this region in the global coronary stents market was that the top players of this market are domiciled in the U.S., where they introduce their product and gain early-bird advantage in the market. Europe is the second largest market for coronary stents, followed by Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing regional market for coronary stents. The market growth in this region will be majorly attributed to the increasing incidences of various CADs, high unmet needs of the patient pool, increasing awareness as well as affordability of the patient population of this region and increasing penetration by U.S. and Europe-based coronary stent manufacturers.
Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic, Inc., Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, C. R. Bard, Inc., Biotronik SE & Co. KG, amg International GmbH, Cook Medical, Inc., Stentys SA and MicroPort Scientific Corporation are the major companies engaged in the development, manufacturing and commercialization of various types of coronary stents. These players are in constant competition with each other in order to gain a competitive edge over others by introducing new materials or methods into their existing coronary stent products.
This report studies the current as well as future prospects of the coronary stents market globally. At present, there are several individuals around the world who require percutaneous coronary interventions (PCIs) due some form of coronary artery diseases (CADs), such as angina pectoris and acute myocardial infarction, regardless of their gender, age or geographic location. There are various types of coronary stents currently available worldwide, which are utilized during PCIs for treating CADs. Coronary stents are tubular structures, which are majorly made of thin mesh of metal wires, and many a time covered with a biodegradable material that contains the drug. However, at present whole stents that are made of a biodegradable material that wholly gets absorbed in the tissues over time are also available in the global market. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments that are contained in the report. It also provides an overall information and data analysis of the global coronary stents market with respect to market segments based on product type as well as geographic regions.
The market for coronary stents is categorized into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. Each of the market segments has been extensively analyzed based on their commercial existence, efficacy, sales revenue and geographic presence. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019. The report also provides compounded annual growth rate (CAGR %) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.
The global coronary stents market has been further categorized into four geographical regions - North America, Europe, Asia-Pacific, and Rest of the World (RoW). The market sizes and forecasts for each of these regions have been provided for the period 2011 to 2019 along with their respective CAGRs (%) for the forecast period 2013 to 2019, considering 2012 as the base year. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the market environmental factors responsible for driving and restraining growth of the global coronary stents market and future opportunities have been provided in the market overview section. This section of the report also deals with market attractiveness analysis, Porter’s five forces analysis and key players’ market share analysis in 2012 in order to give a thorough analysis of the overall competitive scenario in the global coronary stents market.
The report also comprises a section on pipeline overview for this market that includes qualitative analysis for various coronary stents currently under phase II, III & IV clinical trials, which are expected to be launched during the forecast period. Some of the major coronary stents, which are in different stages of clinical trials included in this report are CORACTO, EXCELLA II and EXCELLA BD, DESolve Nx and DESolve FIM, ZoMaxx I and ZoMaxx II, ABSORB STEMI, BioFreedom, TAXUS PERSEUS and BioNIR. A list of recommendations has been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their share in the global coronary stents market.
The report also profiles major players of the global coronary stents market based on various attributes such as company overview, financial overview, product portfolio, business strategies and recent developments. The major players profiled in this report include Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic, Inc., Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, and C. R. Bard, Inc., Cook Medical, Inc., AMG International GmbH, Biotronik SE & Co. KG, Stentys SA and MicroPort Scientific Corporation.
The global coronary stents market is segmented as follows:
Coronary Stents Market, by Product Type
- Bare Metal Stents
- Drug Eluting Stents
- Bio-absorbable Stents
Coronary Stents Market, by Geography
- North America
- Rest of the World (RoW)